coordination center, under the leadership of the endocrinology center, whose president is ivan ivanovich dedovdocrinologist of the ministry of health. the following measure provides for provision of children with diabetes mellitus of the first such as a continuous glucose monitoring system, today they are provided at the expense of the subject, we will support the regions for stability. today, four medical products are registered, this is continuous glucose monitoring, two of which are from friendly countries, in addition, and domestic manufacturers are already developing monitoring systems made by us, according to the developers, it is planned to enter clinical trials in the first half of 24 research. and the fifth group is an important component - this is scientific and technological development. drugs are in great demand today, and i want to note that an original drug for the treatment of diabetes, type 2, has been developed today by domestic manufacturers, and domestic drugs with the active substance, simoglutite, are undergoing the registration procedure, they will replace a foreign drug